XBiotech Inc (XBIT) — Cash Flow-to-Debt Ratio
XBiotech Inc (XBIT) has a Cash Flow-to-Debt Ratio of -2.36x as of December 2025, meaning its operating cash flow of $-22.95 Million could theoretically repay -2% of its total liabilities ($9.73 Million) in one year. See XBiotech Inc (XBIT) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
XBiotech Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for XBiotech Inc across 14 annual periods. For the full cash flow conversion analysis, see XBiotech Inc (XBIT) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for XBiotech Inc (2012–2025)
Year-by-year debt coverage analysis for XBiotech Inc. Check XBiotech Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.10x | $-39.92 Million | $9.73 Million | ▼ -122.9% |
| 2024 | -1.84x | $-30.96 Million | $16.82 Million | ▲ +23.6% |
| 2023 | -2.41x | $-18.73 Million | $7.77 Million | ▲ +7.3% |
| 2022 | -2.60x | $-14.82 Million | $5.70 Million | ▼ -121.7% |
| 2021 | 11.99x | $69.44 Million | $5.79 Million | ▲ +194.0% |
| 2020 | -12.76x | $-65.15 Million | $5.11 Million | ▼ -4178.1% |
| 2019 | -0.30x | $-18.27 Million | $61.25 Million | ▲ +94.7% |
| 2018 | -5.61x | $-16.54 Million | $2.95 Million | ▲ +53.1% |
| 2017 | -11.97x | $-33.65 Million | $2.81 Million | ▼ -107.8% |
| 2016 | -5.76x | $-46.02 Million | $7.99 Million | ▼ -9.1% |
| 2015 | -5.28x | $-33.31 Million | $6.31 Million | ▼ -42.0% |
| 2014 | -3.72x | $-11.70 Million | $3.15 Million | ▲ +64.7% |
| 2013 | -10.54x | $-8.91 Million | $845.00K | ▲ +0.6% |
| 2012 | -10.61x | $-11.63 Million | $1.10 Million | — |